Why Did RxSight Plunge 49.27%? Revenue Forecast Cut

On July 9, 2025, RxSight's stock experienced a significant drop of 49.27% in pre-market trading, marking a substantial decline in its share price.

RxSight Inc. recently revised its 2025 revenue forecast, which has had a notable impact on its stock performance. The company initially projected its 2025 revenue to be between $160 million and $175 million, but this forecast was adjusted to a lower range of $120 million to $130 million. This revision came after the company reported a 4% year-over-year decrease in its preliminary second-quarter revenue, which stood at $33.6 million.

The downward revision in revenue expectations has led to a significant decline in investor confidence, resulting in a sharp drop in the company's stock value. Despite this recent downturn, RxSight's stock had previously shown strong performance, particularly in May when Wells Fargo upgraded its rating from Equal-Weight to Overweight and raised its price target from $17 to $25.